896 research outputs found
ΠΠ°ΡΡΠΈΡΠΈΠ²Π½ΡΠ΅ ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΡ ΡΠΎΠ½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠ΅ΡΠΌΠΈΠ½ΠΎΠ² Π²ΠΎ ΡΡΠ°Π½ΡΡΠ·ΡΠΊΠΎΠΌ ΡΠ·ΡΠΊΠ΅
The paper views partitive relations of French phonetic terms as kind of hierarchical semantic relations which are necessary for terminological field creating of the subject domain βphoneticsβ.Π ΡΡΠ°ΡΡΠ΅ ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°ΡΡΡΡ ΠΏΠ°ΡΡΠΈΡΠΈΠ²Π½ΡΠ΅ ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΡ ΡΠΎΠ½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ΅ΡΠΌΠΈΠ½ΠΎΠ² ΡΡΠ°Π½ΡΡΠ·ΡΠΊΠΎΠ³ΠΎ ΡΠ·ΡΠΊΠ° ΠΊΠ°ΠΊ ΠΎΠ΄ΠΈΠ½ ΠΈΠ· Π²ΠΈΠ΄ΠΎΠ² ΠΈΠ΅ΡΠ°ΡΡ
ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ΅ΠΌΠ°Π½ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠΉ, Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΡΡ
Π΄Π»Ρ ΠΏΠΎΡΡΡΠΎΠ΅Π½ΠΈΡ ΡΠ΅ΡΠΌΠΈΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΠΎΠ»Ρ ΠΏΡΠ΅Π΄ΠΌΠ΅ΡΠ½ΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ "ΡΠΎΠ½Π΅ΡΠΈΠΊΠ°"
ΠΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠ½ΠΈΠΉ ΡΠΊΠ»Π°Π΄ Π΅ΡΡΡΠ½ΠΎΡ ΠΎΠ»ΡΡ Π³ΡΡΡΠ°ΠΊΠ° ΠΏΠΎΡΠ΅ΡΡΠΉΠ½ΠΎΠ³ΠΎ
The composition of the essential oil obtained of Polygonum persicaria L. and was analyzed by GC-MS. The study established the qualitative and quantitative composition of the essential oil content. The total content of essential oil in the herb Polygonum persicaria L. amounted to 1,10Β±0,09%. The major components of the oils of Polygonum persicaria L. were 1,2-benzenedicarboxylic acid, hexadecanoic acid, hexacosone, oleic acid, tricosane, docosane.ΠΠΏΠ΅ΡΠ²ΡΠ΅ Π±ΡΠ»ΠΎ ΠΏΠΎΠ»ΡΡΠ΅Π½ΠΎ ΡΡΠΈΡΠ½ΠΎΠ΅ ΠΌΠ°ΡΠ»ΠΎ Ρ ΡΡΠ°Π²Ρ Π³ΠΎΡΡΠ° ΠΏΠΎΡΠ΅ΡΡΠΉΠ½ΠΎΠ³ΠΎ (Polygonum persicaria L.) ΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ Π΅Π³ΠΎ Π°Π½Π°Π»ΠΈΠ· ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Ρ
ΡΠΎΠΌΠ°ΡΠΎ-ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΠΈ. Π Ρ
ΠΎΠ΄Π΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΡΡΠ°Π½ΠΎΠ²ΠΈΠ»ΠΈ ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠΉ ΡΠΎΡΡΠ°Π² ΠΈ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠ΅ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΡΡΠΈΡΠ½ΠΎΠ³ΠΎ ΠΌΠ°ΡΠ»Π°. Π‘ΡΠΌΠΌΠ°ΡΠ½ΠΎΠ΅ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΡΡΠΈΡΠ½ΠΎΠ³ΠΎ ΠΌΠ°ΡΠ»Π° Π² ΡΡΠ°Π²Π΅ Π³ΠΎΡΡΠ° ΠΏΠΎΡΠ΅ΡΡΠΉΠ½ΠΎΠ³ΠΎ ΡΠΎΡΡΠ°Π²Π»ΡΠ»ΠΎ Π΄ΠΎ 1,10Β±0,09%. ΠΡΠ΅ΠΎΠ±Π»Π°Π΄Π°Π»ΠΈ ΡΠ»Π΅Π΄ΡΡΡΠΈΠ΅ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΡ: ΡΡΠ°Π»Π΅Π²Π°Ρ ΠΊΠΈΡΠ»ΠΎΡΠ°, ΠΏΠ°Π»ΡΠΌΠΈΡΠΈΠ½ΠΎΠ²Π°Ρ ΠΊΠΈΡΠ»ΠΎΡΠ°, Π³Π΅ΠΊΡΠ°ΠΊΠΎΠ·Π°Π½, ΠΎΠ»Π΅ΠΈΠ½ΠΎΠ²Π°Ρ ΠΊΠΈΡΠ»ΠΎΡΠ°, ΡΡΠΈΠΊΠΎΠ·Π°Π½, Π΄Π΅ΠΊΠ°Π½.ΠΠΏΠ΅ΡΡΠ΅ Π±ΡΠ»Π° ΠΎΡΡΠΈΠΌΠ°Π½Π° Π΅ΡΡΡΠ½Π° ΠΎΠ»ΡΡ Π· ΡΡΠ°Π²ΠΈ Π³ΡΡΡΠ°ΠΊΡ ΠΏΠΎΡΠ΅ΡΡΠΉΠ½ΠΎΠ³ΠΎ (Polygonum persicaria L.) Π· ΠΏΠΎΠ΄Π°Π»ΡΡΠΈΠΌ ΡΡ Π°Π½Π°Π»ΡΠ·ΠΎΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Ρ
ΡΠΎΠΌΠ°ΡΠΎ-ΠΌΠ°Ρ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΡΡ. Π Ρ
ΠΎΠ΄Ρ Π΄ΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½Π½Ρ Π²ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΠΉ ΡΠΊΡΡΠ½ΠΈΠΉ ΡΠΊΠ»Π°Π΄ ΡΠ° ΠΊΡΠ»ΡΠΊΡΡΠ½ΠΈΠΉ Π²ΠΌΡΡΡ Π΅ΡΡΡΠ½ΠΎΡ ΠΎΠ»ΡΡ (Π΄ΠΎ 1,10Β±0,09 %). Π ΡΠΊΠ»Π°Π΄Ρ ΠΏΠ΅ΡΠ΅Π²Π°ΠΆΠ°Π»ΠΈ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠΈ: ΡΡΠ°Π»Π΅Π²Π° ΠΊΠΈΡΠ»ΠΎΡΠ°, ΠΏΠ°Π»ΡΠΌΡΡΠΈΠ½ΠΎΠ²Π° ΠΊΠΈΡΠ»ΠΎΡΠ°, Π³Π΅ΠΊΡΠ°ΠΊΠΎΠ·Π°Π½, ΠΎΠ»Π΅ΡΠ½ΠΎΠ²Π° ΠΊΠΈΡΠ»ΠΎΡΠ°, ΡΡΠΈΠΊΠΎΠ·Π°Π½, Π΄Π΅ΠΊΠ°Π½
Naked barley: taxonomy, breeding, and prospects of utilization
This review surveys the current state of taxonomy, origin, and utilization prospects for naked barley. The cultivated barley Hordeum vulgare L. incorporates the covered and naked barley groups. Naked barleys are divided into six-row naked barley (convar. Ρoeleste (L.) A. Trof.) and two-row naked barley (convar. nudum (L.) A. Trof.). The groups include botanical varieties differing in the structural features of spikes, awns, floret and spikelet glumes, and the color of kernels. The centers of morphogenesis for naked barley are scrutinized employing archeological and paleoethnobotanical data, and the diversity of its forms. Hypotheses on the centers of its origin are discussed using DNA marker data. The main areas of its cultivation are shown, along with possible reasons for such a predominating or exclusive distribution of naked barley in highland areas. Inheritance of nakedness and mechanisms of its manifestation are considered in the context of new data in genetics. The biochemical composition of barley grain in protein, some essential and nonessential amino acids, Ξ²-glucans, vitamins, and antioxidants is described. Naked barley is shown to be a valuable source of unique combinations of soluble and insoluble dietary fibers and polysaccharides. The parameters limiting wider distribution of naked barley over the world are emphasized, and breeding efforts that could mitigate them are proposed. Pathogen-resistant naked barley accessions are identified to serve as promising sources for increasing grain yield and quality. Main stages and trends of naked barley breeding are considered and the importance of the VIR global germplasm collection as the richest repository of genetic material for the development of breeding is shown
Anthocyanin content in grains of barley and oat accessions from the VIR collection
Background. Barley (Hordeum vulgareΒ L.) and oat (Avena sativaΒ L.) are grain crops belonging to one of the main sources of food and forage in the Russian Federation. They contain proteins, various groups of vitamins, fats, carbohydrates, Ξ²-glucans, minerals and different bioloactive compounds, including anthocyanins. Recently, much attention has been given to anthocyanins due to their various valuable properties. Therefore, the grain of barley and oat is a potentially promising economic product and a component of functional nutrition. The aim of this work was to estimate the content of anthocyanins in barley and oat accessions with different pigmentation of kernels and lemma. Materials and methods. 32 barley and 11 oat accessions were studied by spectrophotometry. Anthocyanins were extracted from barley and oat kernels with a 1% HCl solution in methanol. Results and discussion. As a result of the study, accessions and varieties with the highest content of anthocyanins were identified: for barley these are k-15904 (China), k-19906 (Mongolia), k-18709 (Japan), k-18723, k-18729 (Canada), k-17725 (Turkey) belonging to var. violaceum; k-29568 (Japan)Β β var. densoviolaceum; k-8690 (Ethiopia)Β β var. griseinigrum; k-28205 (Germany)Β β var. nudidubium; and for oat these are k-15527 (A.Β ayssinica Hochst. var. braunii Koern., Ethiopia) and k-15245 (A.Β strigosa Schreb. subsp. brevis var. tephera Mordv. ex Sold. et Rod., Poland). Conclusion. The obtained results demonstrated that the VIR collection includes accessions with potential value for the development of varieties with an increased anthocyanin content, which can be used as functional food products
EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS
Aim. To study the effect of sacubitril/valsartan compared with valsartan on natriuresis, diuresis, blood pressure (BP) and the level of biomarkers in hypertensive patients.Material and methods. Hypertensive patients (n=16) received sacubitril/valsartan 400 mg QD or valsartan 320 mg QD for 7 days in a double-blind,-randomized, cross-over study. The change in 24-hour diuresis and natriuresis, fractional urinary sodium excretion, and BP level have been studied, as-well as soluble biomarkers: cyclic guanosine monophosphate (cGMP), plasma brain natriuretic peptide (BNP), mid-regional precursor of the atrial natriuretic-peptide (MR-proANP) and the N-terminal precursor of the brain natriuretic peptide (NT-proBNP).Results. The trend toward higher levels of 24-hour natriuresis on Day 1 (21%, p=0.068) was found in the sacubitril/valsartan group compared to-valsartan one. Fractional sodium excretion was significantly higher in the sacubitril/valsartan group on Day 1 after 6 hours (50%, p=0.004) and subsequent-samples up to 12 hours; the maximum effect was achieved 2-4 hours after taking the medication (mean value 2.08, p=0.005). Sacubitril/valsartan-therapy compared with valsartan therapy was associated with a significant increase in 24-hour diuresis on Day 1 (41%, p<0.05), but not on Day 7-(15%, p=0.134). Sacubitril/valsartan therapy, in contrast to valsartan therapy demonstrated a significant increase in 24 h cGMP urinary excretion-on Day 1 (95%, p<0.001) and Day 7 (83%, p=0.001). Sacubitril/valsartan lowered BP more effectively than valsartan [on Day 7, 12 hours after-taking the drug, the differences were13.6 mm Hg (p=0.004) for systolic and6.7 mm Hg (p=0.03) for diastolic BP. The decrease in the level of-NT-proBNP and MR-proANP in plasma and the transient increase in the level of BNP were found in the sacubitril/valsartan group. Both sacubitril/valsartan and valsartan therapies were well tolerated and safe.Conclusion. Sacubitril/valsartan therapy in hypertensive patients compared with valsartan therapy was associated with transient increase in natriuresis and diuresis, more pronounced decrease in BP and changes in biomarker levels reflecting persistent inhibition of neprilysin and decrease in myocardial wall tension
The Role of CYP1A1 Gene Polymorphism in Patients with Erysipelas
Β© 2017, Springer Science+Business Media, LLC. The research aims are to study the role of CYP1A1 gene polymorphism in predisposition to erysipelas and reveal connections with the clinical course of the disease. We used the standard techniques of molecular genetic analysis. The DNA samples used in genotyping were extracted from leukocytes of venous blood by deproteinization with a phenol-chloroform mixture. Genotyping was performed by polymerase chain reaction (PCR). Statistical data relating to the investigated polymorphic markers were estimated at a 95% confidence level (CL). Genotype frequencies were compared using either the standard Pearsonβs chi-squared test or the two-sided Fisherβs exact test. This study presents a comparative analysis of the distribution of gene polymorphisms of cytochrome P450 CYP1A1 (Ile462Val, rs1048943) of phase I detoxification (microsomal oxidation) in the experimental group of 71 patients with erysipelas and a control group of 71 healthy individuals. We also analyzed these relationships of CYP1A1 (Ile462Val) gene polymorphisms with the sex of the patients, the severity and multiplicity of the disease, and the nature of the local process in patients with erysipelas. The results of the investigation indicate the presence of a relationship between cytochrome P450 CYP1A1 (Ile462Val, rs1048943) gene polymorphism and the development of erysipelas. Analysis of these relationships of CYP1A1 (Ile462Val) gene polymorphism with the sex of the patients, the severity and multiplicity of the disease, and the nature of the process in the examined group of patients with erysipelas did not reveal any statistically significant differences
ABOUT MEASURES TO PREVENT IMPORTATION AND DISSEMINATION OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) AT MAGADANSKAYA PROVINCE TERRITORY
Threat of SARS importation and dissemination at the territory of Magadanskaya Province is conditioned first ofΒ all by wide international relations with countries of SouthEast Asia carried out through airport and sea tradeΒ port. In this connection large organizing and practical activities on the basis of Β«A complex plan on sanitaryΒ protection of Magadanskaya Province territory from importation and dissemination of quarantine and otherΒ especially dangerous infectionsΒ» are realized. All concerned Departments and Services took part in realization of the preventive measures. The developed and realized complex of anti-epidemic and preventive measuresΒ allowed to create obstacles to SARS importation on the territory of Magadanskaya Province
Π ΠΠ‘Π¨ΠΠ ΠΠΠΠ Π ΠΠΠΠ§ΠΠΠ ΠΠΠΠΠΠΠΠΠ ΠΠΠ ΠΠΠΠΠΠΠΠ― Π©ΠΠΠΠ§ΠΠ«Π₯ ΠΠΠ’ΠΠΠΠΠ Π ΠΠΠΠ¬Π¦ΠΠ― ΠΠΠ’ΠΠΠΠ ΠΠΠΠΠΠΠΠΠ Π€ΠΠ’ΠΠΠΠ’Π ΠΠ Π‘Π Π‘ΠΠΠΠ’Π ΠΠΠΠ’Π ΠΠ Β«ΠΠΠΠΠΠΒ»
At the Novosibirsk Chemical Concentrates Plant, the determination of alkali metals and calcium in the range of 0.1β100 mg/l is carried out using atomic emission spectra excited in an air-acetylene flame and recorded in the range of 390β860 nm. When these elements are analyzed simultaneously in a wide range of concentrations, the accumulation time of the analytical signal (exposure) is determined by the minimum concentration of calcium. However, at this exposure, the highly sensitive lines of sodium and potassium do not provide the analysis in the entire concentration range, since at large values, the analytical signal goes into saturation. Other analytical lines of potassium and sodium in the above-mentioned operating spectral range have three to four orders of magnitude lower sensitivity. As a result, there may be a gap in the range of detectable concentrations. This paper provides a way to eliminate this gap. To evaluate the degree of correction of the recorded signal, the relative intensities of the spectral lines of potassium and sodium excited in an air-acetylene flame are calculated. Then, based on the calculation results, an optimal echelette diffraction grating with a blaze angle of 300 nm is selected, and a combination of filters is installed to equalize the recorded radiation. As a result, for sodium and potassium, for which the determination is carried out along two analytical lines, the calibration dependences have an overlap that includes at least two concentration values.Keywords: Alkali metals, calcium, flame photometry, diffraction grating, light filters, dynamic range of calibration curvesΒ DOI: http://dx.doi.org/10.15826/analitika.2021.25.4.003Β I.A. Zarubin1, 2, 3, A.N. Putmakov1, 3, E.A. Lukina4, D.O. Selunin1, 3, Π°nd I.D. Burumov1, 3Β 1Institute of Automation and Electrometry, Siberian Branch, Russian Academy of Sciences, pr. AkademikaKoptyuga 1, Novosibirsk, 630090,Β Russian Federation2Novosibirsk State Technical University, pr. K. MarksaΒ 20, Novosibirsk, 630073, Russian Federation3VMK-Optoelektronika, pr. Koptyuga, 1, Novosibirsk, 630090, Russian Federation4Novosibirsk Chemical Concentrates Plant, ul. B. Khmelnitskogo, Β 94, Novosibirsk, 630110, Russian FederationΠΠΎ Π°ΡΠΎΠΌΠ½ΠΎ-ΡΠΌΠΈΡΡΠΈΠΎΠ½Π½ΡΠΌ ΡΠΏΠ΅ΠΊΡΡΠ°ΠΌ, Π²ΠΎΠ·Π±ΡΠΆΠ΄Π°Π΅ΠΌΡΠΌ Π² Π²ΠΎΠ·Π΄ΡΡΠ½ΠΎ-Π°ΡΠ΅ΡΠΈΠ»Π΅Π½ΠΎΠ²ΠΎΠΌ ΠΏΠ»Π°ΠΌΠ΅Π½ΠΈ ΠΈ ΡΠ΅Π³ΠΈΡΡΡΠΈΡΡΠ΅ΠΌΡΠΌ Π² Π΄ΠΈΠ°ΠΏΠ°Π·ΠΎΠ½Π΅ 390-860 Π½ΠΌ, Π½Π° ΠΠΎΠ²ΠΎΡΠΈΠ±ΠΈΡΡΠΊΠΎΠΌ Π·Π°Π²ΠΎΠ΄Π΅ Ρ
ΠΈΠΌΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΎΠ² ΠΏΡΠΎΠ²ΠΎΠ΄ΡΡ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ 0.1-100 ΠΌΠ³/Π» ΡΠ΅Π»ΠΎΡΠ½ΡΡ
ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠ² ΠΈ ΠΊΠ°Π»ΡΡΠΈΡ. ΠΡΠΈ ΠΈΡ
ΠΎΠ΄Π½ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΌ ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½ΠΈΠΈ Π² ΡΠΈΡΠΎΠΊΠΎΠΌ ΠΈΠ½ΡΠ΅ΡΠ²Π°Π»Π΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΉ Π²ΡΠ΅ΠΌΡ Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½ΠΈΡ Π°Π½Π°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠ³Π½Π°Π»Π° ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ΅ΡΡΡ ΠΌΠΈΠ½ΠΈΠΌΠ°Π»ΡΠ½ΠΎΠΉ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠ΅ΠΉ ΠΊΠ°Π»ΡΡΠΈΡ Π² ΠΏΡΠΎΠ±Π΅. ΠΠ΄Π½Π°ΠΊΠΎ, ΠΏΡΠΈ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠΈ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΡΠ΅Π³ΠΈΡΡΡΠ°ΡΠΈΠΈ ΡΠΈΠ³Π½Π°Π»Π°, ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΡΡΡ Π²ΡΡΠΎΠΊΠΎΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΡΡ
Π»ΠΈΠ½ΠΈΠΉΒ Π½Π°ΡΡΠΈΡ ΠΈ ΠΊΠ°Π»ΠΈΡ ΡΡ
ΠΎΠ΄ΠΈΡ Π² Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅, ΡΡΠΎ Π½Π΅ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΠΎΠ±Π΅ΡΠΏΠ΅ΡΠΈΡΡ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΠΈΡ
ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ Π²ΠΎ Π²ΡΠ΅ΠΌ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΠΌ Π΄ΠΈΠ°ΠΏΠ°Π·ΠΎΠ½Π΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΉ. ΠΡΡΠ³ΠΈΠ΅ Π°Π½Π°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π»ΠΈΠ½ΠΈΠΈ ΠΊΠ°Π»ΠΈΡ ΠΈ Π½Π°ΡΡΠΈΡ Π² ΡΠΊΠ°Π·Π°Π½Π½ΠΎΠΉ Π²ΡΡΠ΅ ΡΠ°Π±ΠΎΡΠ΅ΠΉ ΡΠΏΠ΅ΠΊΡΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ ΠΎΠ±Π»Π°Π΄Π°ΡΡ Π½Π° 3-4 ΠΏΠΎΡΡΠ΄ΠΊΠ° ΠΌΠ΅Π½ΡΡΠ΅ΠΉ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡΡ. Π ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ ΡΡΠΎΠ³ΠΎ Π²ΠΎΠ·Π½ΠΈΠΊΠ°Π΅Ρ ΡΠ°Π·ΡΡΠ² Π² Π΄ΠΈΠ°ΠΏΠ°Π·ΠΎΠ½Π΅ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ΅ΠΌΡΡ
ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΉ. Π ΡΠ°Π±ΠΎΡΠ΅ ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΡΡΡ ΡΠΏΠΎΡΠΎΠ± ΡΡΡΡΠ°Π½Π΅Π½ΠΈΡ Π΄Π°Π½Π½ΠΎΠ³ΠΎ ΡΠ°Π·ΡΡΠ²Π°. ΠΠ»Ρ ΠΎΡΠ΅Π½ΠΊΠΈ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΠΉ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΠΈ ΡΠ΅Π³ΠΈΡΡΡΠΈΡΡΠ΅ΠΌΠΎΠ³ΠΎ ΡΠΈΠ³Π½Π°Π»Π° ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ ΡΠ°ΡΡΠ΅Ρ ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΡΡΠ΅ΠΉ ΡΠΏΠ΅ΠΊΡΡΠ°Π»ΡΠ½ΡΡ
Π»ΠΈΠ½ΠΈΠΉ ΠΊΠ°Π»ΠΈΡ ΠΈ Π½Π°ΡΡΠΈΡ, Π²ΠΎΠ·Π±ΡΠΆΠ΄Π°Π΅ΠΌΡΡ
Π² Π²ΠΎΠ·Π΄ΡΡΠ½ΠΎ-Π°ΡΠ΅ΡΠΈΠ»Π΅Π½ΠΎΠ²ΠΎΠΌ ΠΏΠ»Π°ΠΌΠ΅Π½ΠΈ. ΠΠ°Π»Π΅Π΅, Ρ ΡΡΠ΅ΡΠΎΠΌ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΡΠ°ΡΡΠ΅ΡΠ°, Π±ΡΠ»Π° Π²ΡΠ±ΡΠ°Π½Π° ΠΎΠΏΡΠΈΠΌΠ°Π»ΡΠ½Π°Ρ Π΄ΠΈΡΡΠ°ΠΊΡΠΈΠΎΠ½Π½Π°Ρ ΡΠ΅ΡΠ΅ΡΠΊΠ°-ΡΡΠ΅Π»Π΅ΡΡ, ΠΈΠΌΠ΅ΡΡΠ°Ρ ΡΠ³ΠΎΠ» Π±Π»Π΅ΡΠΊΠ° Π΄Π»Ρ 300 Π½ΠΌ, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΏΠΎΠ΄ΠΎΠ±ΡΠ°Π½Π° ΠΊΠΎΠΌΠ±ΠΈΠ½Π°ΡΠΈΡ ΡΠ²Π΅ΡΠΎΡΠΈΠ»ΡΡΡΠΎΠ² Π΄Π»Ρ ΡΠ±Π»ΠΈΠΆΠ΅Π½ΠΈΡ ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΡΡΠ΅ΠΉ ΡΠ΅Π³ΠΈΡΡΡΠΈΡΡΠ΅ΠΌΠΎΠ³ΠΎ ΠΈΠ·Π»ΡΡΠ΅Π½ΠΈΡ ΡΠΏΠ΅ΠΊΡΡΠ°Π»ΡΠ½ΡΡ
Π»ΠΈΠ½ΠΈΠΉ Ρ ΡΠ΅Π·ΠΊΠΎ ΡΠ°Π·Π»ΠΈΡΠ½ΠΎΠΉ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡΡ. Π ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ Π΄Π»Ρ Π½Π°ΡΡΠΈΡ ΠΈ ΠΊΠ°Π»ΠΈΡ, Ρ ΠΊΠΎΡΠΎΡΡΡ
ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΡΡΡ ΠΏΠΎ Π΄Π²ΡΠΌ Π°Π½Π°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠΌ Π»ΠΈΠ½ΠΈΡΠΌ ΡΠ°Π·Π»ΠΈΡΠ½ΠΎΠΉ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ, Π³ΡΠ°Π΄ΡΠΈΡΠΎΠ²ΠΎΡΠ½ΡΠ΅ Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΈΠΌΠ΅ΡΡ ΠΎΠ±Π»Π°ΡΡΡ ΠΏΠ΅ΡΠ΅ΠΊΡΡΡΠΈΡ, Π²ΠΊΠ»ΡΡΠ°ΡΡΡΡ Π½Π΅ ΠΌΠ΅Π½Π΅Π΅ Π΄Π²ΡΡ
Π·Π½Π°ΡΠ΅Π½ΠΈΠΉ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ.ΠΠ»ΡΡΠ΅Π²ΡΠ΅ ΡΠ»ΠΎΠ²Π°. Π©Π΅Π»ΠΎΡΠ½ΡΠ΅ ΠΌΠ΅ΡΠ°Π»Π»Ρ, ΠΊΠ°Π»ΡΡΠΈΠΉ, ΠΏΠ»Π°ΠΌΠ΅Π½Π½Π°Ρ ΡΠΎΡΠΎΠΌΠ΅ΡΡΠΈΡ, Π΄ΠΈΡΡΠ°ΠΊΡΠΈΠΎΠ½Π½Π°Ρ ΡΠ΅ΡΠ΅ΡΠΊΠ°, ΡΠ²Π΅ΡΠΎΡΠΈΠ»ΡΡΡΡ, Π΄ΠΈΠ½Π°ΠΌΠΈΡΠ΅ΡΠΊΠΈΠΉ Π΄ΠΈΠ°ΠΏΠ°Π·ΠΎΠ½ Π³ΡΠ°Π΄ΡΠΈΡΠΎΠ²ΠΎΡΠ½ΡΡ
Π³ΡΠ°ΡΠΈΠΊΠΎΠ²DOI: http://dx.doi.org/10.15826/analitika.2021.25.4.00
ΠΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΡΠΎΡΠ°Π΄ΠΈΠ»Π° Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ Π»Π΅Π³ΠΊΠΈΡ
A course of inhaled therapy with Foradil 12 mcg twice a day for 2 weeks was performed in 12 children with chronic lung diseases manifesting by the bronchoobstructive syndrome. The children's age was 10 to 17 yrs. The clinical and functional efficacy of the drug in children with chronic lung diseases was shown. All the patients demonstrated positive clinical dynamics under the treatment, namely correction of the bronchoobΒstructive syndrome. The positive effect was noted for the first 2 days of the treatment but the defined solution of the obstructive signs was obtained for 2 to 4 days of the therapy in 9 patients and to 7-9-th day in 3 patients. The positive clinical change was accompanied by improvement in the lung function. Any adverse effects of the drug were not found.ΠΡΠΎΠ²Π΅Π΄Π΅Π½ ΠΊΡΡΡ ΠΈΠ½Π³Π°Π»ΡΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ ΡΠΎΡΠ°Π΄ΠΈΠ»ΠΎΠΌ 12 Π΄Π΅ΡΡΠΌ Ρ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ Π»Π΅Π³ΠΊΠΈΡ
, ΠΏΡΠΎΡΠ΅ΠΊΠ°ΡΡΠΈΠΌΠΈ Ρ Π±ΡΠΎΠ½Ρ
ΠΎΠΎΠ±ΡΡΡΡΠΊΡΠΈΠ²Π½ΡΠΌ ΡΠΈΠ½Π΄ΡΠΎΠΌΠΎΠΌ, Π² Π΄ΠΎΠ·Π΅ 12 ΠΌΠΊΠ³ 2 ΡΠ°Π·Π° Π² ΡΡΡΠΊΠΈ Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ 2 Π½Π΅Π΄. ΠΠΎΠ·ΡΠ°ΡΡ Π΄Π΅ΡΠ΅ΠΈΜ ΡΠΎΡΡΠ°Π²Π»ΡΠ» 10-17 Π»Π΅Ρ. ΠΠΎΠΊΠ°Π·Π°Π½Π° ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΈ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° Ρ Π΄Π΅ΡΠ΅ΠΈΜ Ρ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ Π»Π΅Π³ΠΊΠΈΡ
. ΠΠ° ΡΠΎΠ½Π΅ Π»Π΅ΡΠ΅Π½ΠΈΡ Ρ Π²ΡΠ΅Ρ
Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΏΠΎΠ»ΡΡΠ΅Π½Π° ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½Π°Ρ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠ°Ρ Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ°, Π·Π°ΠΊΠ»ΡΡΠ°Π²ΡΠ°ΡΡΡ Π² Π»ΠΈΠΊΠ²ΠΈΠ΄Π°ΡΠΈΠΈ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΠΈΜ Π±ΡΠΎΠ½Ρ
ΠΎΠΎΠ±ΡΡΡΡΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ°. ΠΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΡΠΈΜ ΡΡΡΠ΅ΠΊΡ ΠΎΡΠΌΠ΅ΡΠ΅Π½ Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ ΠΏΠ΅ΡΠ²ΡΡ
Π΄Π²ΡΡ
Π΄Π½Π΅ΠΈΜ Π»Π΅ΡΠ΅Π½ΠΈΡ, Π½ΠΎ ΠΎΠΊΠΎΠ½ΡΠ°ΡΠ΅Π»ΡΠ½Π°Ρ Π»ΠΈΠΊΠ²ΠΈΠ΄Π°ΡΠΈΡ ΠΏΡΠΈΠ·Π½Π°ΠΊΠΎΠ² Π±ΡΠΎΠ½Ρ
ΠΎΠΎΠ±ΡΡΡΡΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° ΠΎΡΠΌΠ΅ΡΠ΅Π½Π° Ρ 9 Π±ΠΎΠ»ΡΠ½ΡΡ
Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ 2-4 Π΄Π½Π΅ΠΈΜ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ, Ρ 3 Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΊ 7-9-ΠΌΡ Π΄Π½Ρ Π»Π΅ΡΠ΅Π½ΠΈΡ. ΠΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½Π°Ρ Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ° ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠΈΠΌΠΏΡΠΎΠΌΠΎΠ² ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°Π»Π°ΡΡ ΡΠ»ΡΡΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΈΜ ΡΡΠ½ΠΊΡΠΈΠΈ Π²Π½Π΅ΡΠ½Π΅Π³ΠΎ Π΄ΡΡ
Π°Π½ΠΈΡ. ΠΠΎΠ±ΠΎΡΠ½ΡΡ
ΡΡΡΠ΅ΠΊΡΠΎΠ² Π΄Π΅ΠΈΜΡΡΠ²ΠΈΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° Π²ΡΡΠ²Π»Π΅Π½ΠΎ Π½Π΅ Π±ΡΠ»ΠΎ
Π¦ΠΠ ΠΠΠ ΠΠΠ¬ΠΠ«Π ΠΠΠΠΠΠΠ«Π Π’Π ΠΠΠΠΠΠ«: ΠΠΠΠΠΠΠΠΠ‘Π’Π Π‘ΠΠΠ ΠΠΠΠΠΠ«Π₯ ΠΠ«Π‘ΠΠΠΠ’ΠΠ₯ΠΠΠΠΠΠΠ§ΠΠ«Π₯ ΠΠΠ’ΠΠΠΠ ΠΠ£Π§ΠΠΠΠ ΠΠΠΠΠΠΠ‘Π’ΠΠΠ
The work demonstrates the possibilities of multislice computed tomography (MSCT) and magnetic resonance imaging (MRI) in detecting cerebral venous thrombosis.Π ΡΠ°Π±ΠΎΡΠ΅ ΠΎΠ±ΡΡΠΆΠ΄Π°ΡΡΡΡ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ ΠΌΡΠ»ΡΡΠΈΡΠΏΠΈΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΊΠΎΠΌΠΏΡΡΡΠ΅ΡΠ½ΠΎΠΉ ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΠΈ (ΠΠ‘ΠΠ’) ΠΈ ΠΌΠ°Π³Π½ΠΈΡΠ½ΠΎ-ΡΠ΅Π·ΠΎΠ½Π°Π½ΡΠ½ΠΎΠΉ ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΠΈ (ΠΠ Π’) Π² Π²ΡΡΠ²Π»Π΅Π½ΠΈΠΈ ΡΠ΅ΡΠ΅Π±ΡΠ°Π»ΡΠ½ΡΡ
Π²Π΅Π½ΠΎΠ·Π½ΡΡ
ΡΡΠΎΠΌΠ±ΠΎΠ·ΠΎΠ²
- β¦